Categorical versus continuous circulating tumor cell enumeration as early surrogate marker for therapy response and prognosis during docetaxel therapy in metastatic prostate cancer patients

BACKGROUND: Circulating tumor cell (CTCs) counts might serve as early surrogate marker for treatment efficacy in metastatic castration-resistant prostate cancer (mCRPC) patients. We prospectively assessed categorical and continuous CTC-counts for their utility in early prediction of radiographic res...

Descripción completa

Detalles Bibliográficos
Autores principales: Thalgott, Mark, Rack, Brigitte, Eiber, Matthias, Souvatzoglou, Michael, Heck, Matthias M., Kronester, Caroline, Andergassen, Ulrich, Kehl, Victoria, Krause, Bernd J., Gschwend, Jurgen E., Retz, Margitta, Nawroth, Roman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4459665/
https://www.ncbi.nlm.nih.gov/pubmed/26051431
http://dx.doi.org/10.1186/s12885-015-1478-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4459665/
https://www.ncbi.nlm.nih.gov/pubmed/26051431
http://dx.doi.org/10.1186/s12885-015-1478-4

Ejemplares similares